{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:41:57Z","timestamp":1790635317933,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02479-z","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:02:30Z","timestamp":1662102150000},"page":"795-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tear film impairment and meibomian gland loss in patients with polycystic ovary syndrome"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-0329","authenticated-orcid":false,"given":"Yakup","family":"Acet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan","family":"Sarikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"2479_CR1","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2005-0628","volume":"90","author":"R Azziz","year":"2005","unstructured":"Azziz R, Marin C, Hoq L et al (2005) Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 90:4650\u20134658","journal-title":"J Clin Endocrinol Metab"},{"key":"2479_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"2479_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223\u20131236","journal-title":"N Engl J Med"},{"key":"2479_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G et al (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219\u2013231","journal-title":"Nat Rev Endocrinol"},{"key":"2479_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","volume":"15","author":"D Cibula","year":"2000","unstructured":"Cibula D, C\u00edfkov\u00e1 R, Fanta M et al (2000) Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary arterydisease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15:785\u2013789","journal-title":"Hum Reprod"},{"key":"2479_CR6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00404-014-3353-y","volume":"290","author":"A Gul","year":"2014","unstructured":"Gul A, Mehmet K, Tatar G (2014) Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance. Arch Gynecol Obstet 290:1255\u20131263","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"2479_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ajo.2007.01.030","volume":"143","author":"S Bonini","year":"2007","unstructured":"Bonini S, Mantelli F, Moretti C et al (2007) Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol 143(5):763\u2013771","journal-title":"Am J Ophthalmol"},{"issue":"1\u20132","key":"2479_CR8","first-page":"65","volume":"56","author":"H Coksuer","year":"2011","unstructured":"Coksuer H, Ozcura F, Oghan F et al (2011) Effects of hyperandrogenism on tear function and tear drainage in patients with polycystic ovary syndrome. J Reprod Med 56(1\u20132):65\u201370","journal-title":"J Reprod Med"},{"key":"2479_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0161-6420(95)30861-5","volume":"102","author":"S Bonini","year":"1995","unstructured":"Bonini S, Lambiase A, Schiavone M et al (1995) Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology 102:1374\u20131379","journal-title":"Ophthalmology"},{"issue":"6","key":"2479_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3109\/02713683.2012.749917","volume":"38","author":"T Gonen","year":"2013","unstructured":"Gonen T, Celik C, Oznur M et al (2013) Tear osmolarity and ocular surface changes in patient with polycystic ovary syndrome. Curr Eye Res 38(6):621\u2013625","journal-title":"Curr Eye Res"},{"issue":"2","key":"2479_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1542-0124(12)70147-7","volume":"2","author":"DA Sullivan","year":"2004","unstructured":"Sullivan DA (2004) Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. Ocul Surf 2(2):92\u2013123","journal-title":"Ocul Surf"},{"key":"2479_CR12","first-page":"1261","volume":"40","author":"DA Sullivan","year":"1999","unstructured":"Sullivan DA, Krenzer KL, Sullivan BD et al (1999) Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci 40:1261\u20131265","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2479_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1749-6632.1999.tb07656.x","volume":"876","author":"DA Sullivan","year":"1999","unstructured":"Sullivan DA, Wickham LA, Rocha EM et al (1999) Androgens and dry eye in Sj\u00f6gren\u2019s syndrome. Ann N Y Acad Sci 876:312\u2013324","journal-title":"Ann N Y Acad Sci"},{"key":"2479_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","volume":"286","author":"DA Schaumberg","year":"2001","unstructured":"Schaumberg DA, Buring JE, Sullivan DA et al (2001) Hormone replacement therapy and dry eye syndrome. JAMA 286:2114\u20132119","journal-title":"JAMA"},{"key":"2479_CR15","first-page":"3732","volume":"41","author":"DA Sullivan","year":"2000","unstructured":"Sullivan DA, Sullivan BD, Ullman MD et al (2000) Androgen influence on the meibomian gland. Invest Ophtalmol Vis Sci 41:3732\u20133742","journal-title":"Invest Ophtalmol Vis Sci"},{"key":"2479_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0022-4731(89)90089-7","volume":"34","author":"DA Sullivan","year":"1989","unstructured":"Sullivan DA, Hann LE (1989) Hormonal influence on the secretory immune system of the eye: endocrine impact on the lacrimal gland accumulation and secretion of IgA and IgG. J Steroid Biochem 34:253\u2013262","journal-title":"J Steroid Biochem"},{"key":"2479_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.neo.7900194","volume":"4","author":"S Mitchell","year":"2002","unstructured":"Mitchell S, Abel P, Madaan S et al (2002) Androgen-dependent regulation of human MUC1 mucin expression. Neoplasia 4:9\u201318","journal-title":"Neoplasia"},{"key":"2479_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-4615-5359-5_46","volume":"438","author":"DA Sullivan","year":"1998","unstructured":"Sullivan DA, Rocha EM, Ullman MD et al (1998) Androgen regulation of the meibomian gland. Adv Exp Med Biol 438:327\u2013331","journal-title":"Adv Exp Med Biol"},{"key":"2479_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/02713680701858410","volume":"33","author":"GF Yavas","year":"2008","unstructured":"Yavas GF, Ozturk F, Kusbeci T et al (2008) Meibomian gland alterations in polycystic ovary syndrome. Curr Eye Res 33:133\u2013138","journal-title":"Curr Eye Res"},{"key":"2479_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","volume":"84","author":"E Carmina","year":"1999","unstructured":"Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897\u20131899","journal-title":"J Clin Endocrinol Metab"},{"key":"2479_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4274\/tjo.73659","volume":"47","author":"SK Ad\u0131yeke","year":"2017","unstructured":"Ad\u0131yeke SK, Karaca \u0130, Y\u0131ld\u0131r\u0131m S et al (2017) Anterior segment findings in women with polycystic ovary syndrome. Turk J Ophthalmol 47:24\u201327","journal-title":"Turk J Ophthalmol"},{"key":"2479_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0039-6257(00)00200-9","volume":"45","author":"C Baudouin","year":"2001","unstructured":"Baudouin C (2001) The pathology of dry eye. Surv Ophthalmol 45:211\u2013220","journal-title":"Surv Ophthalmol"},{"key":"2479_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0014-4835(03)00203-3","volume":"78","author":"JP McCulley","year":"2004","unstructured":"McCulley JP, Shine WE (2004) The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res 78:361\u2013365","journal-title":"Exp Eye Res"},{"key":"2479_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.exer.2005.11.026","volume":"83","author":"F Schirra","year":"2006","unstructured":"Schirra F, Richards SM, Liu M et al (2006) Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res 83:291\u2013296","journal-title":"Exp Eye Res"},{"issue":"19","key":"2479_CR25","first-page":"3556","volume":"19","author":"B Yuksel","year":"2015","unstructured":"Yuksel B, Ozturk I, Seven A et al (2015) Tear function alterations in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 19(19):3556\u20133562","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"2479_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.survophthal.2005.02.005","volume":"50","author":"PD Gupta","year":"2005","unstructured":"Gupta PD, Johar K Sr, Nagpal K et al (2005) Sex hormone receptors in the human eye. Surv Ophthalmol 50(3):274\u2013284","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"2479_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/02713683.2016.1233985","volume":"42","author":"G Baser","year":"2017","unstructured":"Baser G, Yildiz N, Calan M (2017) Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res 42(5):661\u2013665","journal-title":"Curr Eye Res"},{"issue":"5","key":"2479_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/02713680701316674","volume":"32","author":"F Schirra","year":"2007","unstructured":"Schirra F, Richards SM, Sullivan DA (2007) Androgen influence on cholesterogenic enzyme mRNA levels in the mouse meibomian gland. Curr Eye Res 32(5):393\u2013398","journal-title":"Curr Eye Res"},{"key":"2479_CR29","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1007\/s11095-005-6306-0","volume":"22","author":"C Leon","year":"2005","unstructured":"Leon C, Hill JS, Wasan KM (2005) Potential role of acyl-coenzyme A: cholesterol transferase (ACAT) inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharm Res 22:1578\u20131588","journal-title":"Pharm Res"},{"key":"2479_CR30","doi-asserted-by":"publisher","first-page":"21324","DOI":"10.1074\/jbc.M002541200","volume":"275","author":"H Yagyu","year":"2000","unstructured":"Yagyu H, Kitamine T, Osuga J et al (2000) Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 275:21324\u201321330","journal-title":"J Biol Chem"},{"key":"2479_CR31","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1167\/iovs.05-0426","volume":"46","author":"F Schirra","year":"2005","unstructured":"Schirra F, Suzuki T, Richards SM et al (2005) Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci 46:3666\u20133675","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2479_CR32","first-page":"4874","volume":"85","author":"KL Krenzer","year":"2000","unstructured":"Krenzer KL, Dana MR, Ullman MD et al (2000) Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocr Metab 85:4874\u20134882","journal-title":"J Clin Endocr Metab"},{"key":"2479_CR33","first-page":"4866","volume":"85","author":"BD Sullivan","year":"2000","unstructured":"Sullivan BD, Evans JE, Krenzer KL et al (2000) Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocr Metab 85:4866\u20134873","journal-title":"J Clin Endocr Metab"},{"key":"2479_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2002.tb04217.x","volume":"966","author":"DA Sullivan","year":"2002","unstructured":"Sullivan DA, Sullivan BD, Evans JE et al (2002) Androgen deficiency, meibomian gland dysfunction and evaporative dry eye. Ann NY Acad Sci 966:211\u2013222","journal-title":"Ann NY Acad Sci"},{"key":"2479_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-1-4615-0717-8_63","volume":"506","author":"BD Sullivan","year":"2002","unstructured":"Sullivan BD, Evans JE, Dana MR et al (2002) Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol 506:449\u2013458","journal-title":"Adv Exp Med Biol"},{"key":"2479_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0378-5122(00)00181-X","volume":"37","author":"C Worda","year":"2001","unstructured":"Worda C, Nepp J, Huber JC et al (2001) Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 37:209\u2013212","journal-title":"Maturitas"},{"key":"2479_CR37","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/archopht.120.12.1689","volume":"120","author":"BD Sullivan","year":"2002","unstructured":"Sullivan BD, Evans JE, Cermak JM et al (2002) Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 120:1689\u20131699","journal-title":"Arch Ophthalmol"},{"key":"2479_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00003226-200308000-00006","volume":"22","author":"JM Cermak","year":"2003","unstructured":"Cermak JM, Krenzer KL, Sullivan RM et al (2003) Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 22:516\u2013521","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02479-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T02:06:35Z","timestamp":1679969195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02479-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["2479"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02479-z","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"10 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Medical University of Harran (HRU\/21.16.17).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}